Literature DB >> 33977154

Trace element levels in pleural effusions.

Deirdre B Fitzgerald1,2,3, Natalia D Popowicz4, John Joseph5, Steele C Butcher6, Marie Westcott5, Ee Mun Lim5, Jenette Creaney2,3,7, Y C Gary Lee1,2,3.   

Abstract

Entities:  

Year:  2021        PMID: 33977154      PMCID: PMC8093853          DOI: 10.1002/hsr2.262

Source DB:  PubMed          Journal:  Health Sci Rep        ISSN: 2398-8835


× No keyword cloud information.

INTRODUCTION

Pleural effusions are common manifestations of a diverse spectrum of disorders. The fluid contents are complex and not yet fully characterized. It is increasingly recognized that pleural fluid contains biologically active contents, including trace elements. These can contribute to disease pathogenesis, exemplified by our recent finding that manganese is an essential growth factor for Streptococcus pneumoniae (a common cause of empyema) in pleural fluid. Trace elements are fundamental to numerous physiological processes in health and disease states. Prior papers have described selected trace elements in specific pleural conditions. , , , In this study, we profiled a large unbiased cohort of well characterized pleural effusions to (a) confirm the presence of six common trace elements (zinc, copper, cobalt, manganese, iron, and molybdenum); and (b) evaluate their relationship with effusion etiology and biochemical characteristics in commonly encountered pleural effusions.

METHODS

Pleural fluid samples from patients presenting to our center are routinely collected with informed consent for biobank storage (approved by the Sir Charles Gairdner and Osborne Park Hospitals Human Research Ethics Committee, RGS0000001516). Fluid is transported in sterile containers to the laboratory, centrifuged at 1000g for 10 minutes and the supernatant stored at −80°C until analysis. Clinical etiology for all selected samples was confirmed by clinician review and samples were classified as previously described. Light's criteria were used to define transudative and exudative effusions. Malignant effusions (defined as per recent clinical trials ) included those containing cancer cells or were otherwise unexplained exudates in patients with known disseminated malignancy. Benign exudates were nonmalignant (including infective) exudative effusions. Effusions secondary to fluid overload were those with low lactate dehydrogenase (LDH) associated with heart, liver, or renal failure. “Six of the eight essential trace elements,” as defined by Frieden, were readily measurable in our laboratory with validated tests and were chosen for analysis. All biochemical analyses were performed in PathWest Laboratory (QEII Medical Centre, Western Australia), a NATA‐accredited facility. Pleural fluid pH analysis was performed using a Radiometer ABL 800 Flex Analyser. Glucose (Hexokinase), protein (Biuret), and LDH (NADH) analyses were performed on the ARCHITECT‐c16000 (Abbott). Concentrations of trace elements and quality control material (Clinchek‐Urine Control, Recipe Chemicals + Instruments GmbH) were determined simultaneously by inductively‐coupled argon‐plasma mass‐spectrometry using the NexION 300D platform (PerkinElmer). Samples were diluted in a 2% nitric acid diluent containing 0.1% Triton‐X100, plus 50 ppm of Internal Standard mix. The acid used for digestion was Suprapur Nitric Acid 65%; Merck Pty Ltd, Darmstadt Germany, Catalog Number 100441. Calibrators were made using a Stock Multi‐Element Standard Solution (100 mg/L). Analysis was performed using Kinetic Energy Discrimination mode with helium as the collision gas for dealing with polyatomic spectral interferences. SPSSv.26 (IBM) was used for statistical analysis. Correlations between variables were reported using Spearman's coefficient (r ). Intergroup comparisons were performed using Mann‐Whitney test or one‐way analysis of variance on‐ranks with Dunn's posthoc test.

RESULTS

Pleural fluid samples (n = 114) from 105 patients were randomly selected from our Biobank and included effusions from malignancies (n = 58), benign exudates (n = 26), and fluid overload (n = 21) (Table 1).
TABLE 1

Patients and pleural fluid characteristics

Patient characteristics (n = 105)
Male, n (%)66(62.9%)
Age, mean (SD)66(12.6)
Diagnosis, n (%)Fluid overload21(20.0%)
Benign exudate26(24.8%)
MPE58(55.2%)
Pleural effusion characteristicsMedianIQR
BiochemistryGlucose (mmol/L)5.6[4.4‐6.8]
LDH (IU/L)267[161‐697]
pH7.36[7.27‐7.42]
Protein (g/L)38[28‐45]
Trace elements a Zinc (μmol/L)6.1[3.3‐8.7]
Copper (μmol/L)9.2[5.85‐16.2]
Cobalt (nmol/L)1.6[1.1‐2.6]
Manganese (nmol/L)10.7[5.6‐17.5]
Iron (μmol/L)7.5[3.5‐16.8]
Molybdenum (nmol/L)7.9[5.1‐16.9]

Limit of detection is 3 × SD of the blanks and the limit of quantification is 10 × SD of blanks.

Patients and pleural fluid characteristics Limit of detection is 3 × SD of the blanks and the limit of quantification is 10 × SD of blanks. The six trace elements were present at measurable levels and in biologically relevant concentrations in all pleural fluid samples (Table 1). Overall, their median concentrations in pleural fluid were higher than (especially for Cu and Mo) or within the normal reference range for blood levels. The pleural fluid levels of trace elements were correlated (Table 2); not only between Zn and Cu (r = 0.794, P < .001) but also between Zn and Mn (r = 0.477), Zn and Fe (r = 0.453), Cu and Mn (r = 0.437), and Fe and Mn (r = 0.728), all P < .001. Overall, pleural fluid trace element levels correlated weakly with the biochemical parameters tested (Table 2).
TABLE 2

Spearman correlation coefficients between pleural fluid trace elements concentrations and with pleural fluid biochemical parameters

ZnCuCoMnFeMo
Znμmol/L
Cuμmol/L 0.794 ***
Conmol/L0.369*** 0.393***
Mnnmol/L 0.477 *** 0.437 *** 0.351***
Feμmol/L 0.453 *** 0.324*** 0.216* 0.728***
Monmol/L0.301* 0.300* 0.229* 0.246* 0.079

P < .05;

P < .01;

P < .001, r  > 0.4 in bold.

Spearman correlation coefficients between pleural fluid trace elements concentrations and with pleural fluid biochemical parameters P < .05; P < .01; P < .001, r  > 0.4 in bold. Zn and Cu were significantly higher in exudates than transudates by 2.59‐ and 2.20‐fold, respectively, P < .001 (Figure 1). Most trace elements showed statistically significant differences in their concentrations among different etiological groups (Figure 2).
FIGURE 1

Trace element levels in transudative (n = 21) vs exudative (n = 84) pleural effusions. ***P < .001

FIGURE 2

Trace element levels according to pleural effusion groups: fluid overload (n = 21), benign exudates (n = 26) and malignant pleural effusions (MPE) (n = 58). *P < .05; **P < .01; ***P < .001

Trace element levels in transudative (n = 21) vs exudative (n = 84) pleural effusions. ***P < .001 Trace element levels according to pleural effusion groups: fluid overload (n = 21), benign exudates (n = 26) and malignant pleural effusions (MPE) (n = 58). *P < .05; **P < .01; ***P < .001

DISCUSSION

This study is the largest on trace elements in pleural fluid in a well‐phenotyped cohort. All six trace elements studied were present in biologically relevant concentrations in pleural fluid but the concentrations varied among underlying disease groups. These data support future functional research to define the pathobiological effects of these trace elements in pleural diseases. The pleural cavity is lined by mesothelial cells. In pathological conditions, influx of cancer and inflammatory cells, fibroblasts, and microbes can occur. Knowledge on effects of trace elements on mesothelial cells, though scarce and limited to in vitro data, suggest that they can actively influence a diverse range of biological events. We recently reported that manganese is important for pneumococci proliferation within pleural effusions. Others found that zinc supplementation blocks the manganese transporter in nonmutant pneumococci by irreversible receptor‐binding. Zinc attenuates reactive oxygen species production and inflammation, whereas cobalt and zinc protoporphyrin regulate toll‐like receptor‐9 expression during infection on mesothelial cells. A recurring outcome in pleural fluid trace element studies is that Zn and Cu are often high in inflamed and infected pleural fluid. We demonstrated that benign exudates contained significantly higher levels of Zn than MPE and transudates, a finding supported by other studies in the past. , , Zn is involved in wound healing and immunity, and functions as an antioxidant. Balkan et al found that serum Zn and protein levels were low in patients with empyema, both increasing in those who received Zn replacement. The reasons for elevated Zn in infection‐related effusions are unknown. Scattered literature suggests a role of trace elements in pleural malignancies. We found higher iron levels in malignant (vs all benign) effusions and higher zinc and copper levels in malignant (vs fluid overload) effusions. Interestingly, iron, as well as overexpression of manganese superoxide dismutase and copper‐zinc superoxide dismutase, has been implicated in carcinogenesis of asbestos‐related cancers. , , Copper‐complexed disulfiram has a proposed role against mesothelioma. The role of trace elements in pleural malignancies may deserve further exploration. We observed that trace element levels were present in high concentrations in pleural fluid (relative to expected blood levels) and their levels were independent of traditional transudate/exudate separation. These observations suggest that transport of trace elements across the pleura involves more than simple diffusion or regulation from Starling's equation. Correlations exist between levels of different trace elements, which may suggest complex coregulatory processes in their biological interactions and transport. Not surprisingly, trace element levels lack value in separating effusions into benign and malignant. , , , , , Given the diverse effects of trace elements, it is likely that they are involved in basic mechanisms underscoring different disease processes and are present in significant concentrations across disease states. We found that various trace elements were differentially expressed in different disease states with significantly elevated concentrations. Whether that suggests an active pathogenic role or if they are innocent bystanders will require functional studies.

CONCLUSION

Trace elements in pleural disease is an unexplored area. Our data showing their presence in high levels and in differential concentrations across disease states support future investigations of trace elements in pleural diseases.

CONFLICT OF INTEREST

The authors have no potential conflicts of interest to declare regarding the work involved in this article.

AUTHOR CONTRIBUTIONS

Conceptualization: Y. C. Gary Lee, Natalia D. Popowicz Data Curation: Deirdre B. Fitzgerald, Natalia D. Popowicz, John Joseph, Steele C. Butcher, Marie Westcott, Ee Mun Lim, Jenette Creaney Formal Analysis: Deirdre B. Fitzgerald, Y. C. Gary Lee Investigation: Deirdre B. Fitzgerald, Natalia D. Popowicz, John Joseph, Steele C. Butcher, Marie Westcott, Ee Mun Lim, Jenette Creaney Methodology: Y. C. Gary Lee, Natalia D. Popowicz Writing—Original Draft Preparation: Deirdre B. Fitzgerald, Y. C. Gary Lee Writing—Review & Editing: Deirdre B. Fitzgerald, Natalia D. Popowicz, John Joseph, Steele C. Butcher, Marie Westcott, Ee Mun Lim, Jenette Creaney All authors have read and approved the final version of the manuscript. Y. C. Gary Lee had full access to all the data in this study and takes complete responsibility for the integrity of the data and the accuracy of the data analysis.
  17 in total

1.  Concentrations of copper, zinc, manganese, rubidium, and magnesium in thoracic empyemata and corresponding sera.

Authors:  W Domej; M Krachler; W Goessler; A Maier; K J Irgolic; J K Lang
Journal:  Biol Trace Elem Res       Date:  2000       Impact factor: 3.738

2.  Diagnostic value of zinc levels in pleural effusions.

Authors:  K E Shepherd
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

3.  Zinc, copper, and iron content of pleural fluid in benign and neoplastic disease.

Authors:  D E Dines; L R Elveback; J T McCall
Journal:  Thorax       Date:  1972-05       Impact factor: 9.139

4.  Pleural effusions and sera from patients with benign or malignant diseases.

Authors:  W Domej; M Krachler; W Goessler; A Maier; K J Irgolic
Journal:  Biol Trace Elem Res       Date:  2000       Impact factor: 3.738

5.  Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial.

Authors:  Sanjeevan Muruganandan; Maree Azzopardi; Deirdre B Fitzgerald; Ranjan Shrestha; Benjamin C H Kwan; David C L Lam; Christian C De Chaneet; Muhammad Redzwan S Rashid Ali; Elaine Yap; Claire L Tobin; Luke A Garske; Phan T Nguyen; Christopher Stanley; Natalia D Popowicz; Christopher Kosky; Rajesh Thomas; Catherine A Read; Charley A Budgeon; David Feller-Kopman; Nick A Maskell; Kevin Murray; Y C Gary Lee
Journal:  Lancet Respir Med       Date:  2018-07-20       Impact factor: 30.700

6.  Copper and zinc levels in normal and malignant tissues.

Authors:  E J Margalioth; J G Schenker; M Chevion
Journal:  Cancer       Date:  1983-09-01       Impact factor: 6.860

7.  Mechanisms of oxidative stress and alterations in gene expression by Libby six-mix in human mesothelial cells.

Authors:  Jedd M Hillegass; Arti Shukla; Maximilian B MacPherson; Sherrill A Lathrop; Vlada Alexeeva; Timothy N Perkins; Albert van der Vliet; Pamela M Vacek; Mickey E Gunter; Brooke T Mossman
Journal:  Part Fibre Toxicol       Date:  2010-09-11       Impact factor: 9.400

8.  Zinc inhibits high glucose-induced NLRP3 inflammasome activation in human peritoneal mesothelial cells.

Authors:  Yi Fan; Xiuli Zhang; Lina Yang; Jun Wang; Ye Hu; Aishu Bian; Jin Liu; Jianfei Ma
Journal:  Mol Med Rep       Date:  2017-08-11       Impact factor: 2.952

9.  Heme Oxygenase-1 Deficiency Diminishes Methicillin-Resistant Staphylococcus aureus Clearance Due to Reduced TLR9 Expression in Pleural Mesothelial Cells.

Authors:  Satindra Gahlot; Najmunnisa Nasreen; Judith A Johnson; Steven A Sahn; Kamal A Mohammed
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

10.  Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis.

Authors:  Vino T Cheriyan; Ying Wang; Magesh Muthu; Shazia Jamal; Di Chen; Huanjie Yang; Lisa A Polin; Adi L Tarca; Harvey I Pass; Q Ping Dou; Sunita Sharma; Anil Wali; Arun K Rishi
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.